Nitric oxide-induced carbonylation of Bcl-2, GAPDH and ANT precedes apoptotic events in insulin-secreting RINm5F cells

Exp Cell Res. 2004 Feb 1;293(1):22-30. doi: 10.1016/j.yexcr.2003.10.004.

Abstract

Generation of high levels of nitric oxide (NO) following induction of NOS2 by interleukin-1 beta (IL-1beta) triggers beta cell apoptosis in insulin-secreting RINm5F cells. Mitochondrial and nuclear events such as downregulation of the antiapoptotic protein Bcl-2, activation of the pore responsible for the permeability transition (PT) and DNA fragmentation are involved in the process. We report in the present paper that exposure of insulin-producing RINm5F cells to NO donors and to IL-1beta leads to oxidative carbonylation of both Bcl-2 and the adenine nucleotide translocator (ANT) component of the mitochondrial PT pore. When the effect of endogenous generation of high concentrations of NO following exposure of cells to IL-1beta was studied, carbonylation of Bcl-2 preceded downregulation of the protein. Overexpression of Mn-SOD decreases substantially the extent of Bcl-2 carbonylation in SIN-1-exposed cells. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibition, carbonylation and translocation from cytoplasm to nucleus and DNA fragmentation were also induced by DETA/NO exposure. DETA/NO-induced carbonylation of Bcl-2 and ANT proteins takes place 6 h before apoptotic release of histone-associated DNA to cytoplasm. Time course studies also reveal a close parallel between GAPDH translocation to nucleus and carbonylation. Inhibitors of lipooxidation end products formation such as piridoxamine (PM) and aminoguanidine (AG) block NO-triggered carbonylation of Bcl-2, ANT and GAPDH, prevent NO-induced GAPDH enzyme inhibition and nuclear translocation and DNA fragmentation. Our results support the notion that the oxidative carbonylation of proteins plays a role in the control of NO-induced apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine Nucleotides / metabolism*
  • Animals
  • Apoptosis / drug effects*
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Cytoplasm / metabolism
  • DEET / pharmacology
  • Free Radical Scavengers
  • Glyceraldehyde-3-Phosphate Dehydrogenases / antagonists & inhibitors
  • Glyceraldehyde-3-Phosphate Dehydrogenases / drug effects
  • Glyceraldehyde-3-Phosphate Dehydrogenases / metabolism*
  • Insulin / metabolism
  • Insulin Secretion
  • Interleukin-1 / pharmacology
  • Kinetics
  • Lipid Peroxidation / drug effects
  • Molsidomine / analogs & derivatives*
  • Molsidomine / pharmacology
  • Nitric Oxide / pharmacology*
  • Nitric Oxide Donors / pharmacology
  • Proto-Oncogene Proteins c-bcl-2 / drug effects
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Rats
  • Superoxide Dismutase / metabolism

Substances

  • Adenine Nucleotides
  • Free Radical Scavengers
  • Insulin
  • Interleukin-1
  • Nitric Oxide Donors
  • Proto-Oncogene Proteins c-bcl-2
  • DEET
  • Nitric Oxide
  • linsidomine
  • Molsidomine
  • Superoxide Dismutase
  • Glyceraldehyde-3-Phosphate Dehydrogenases